Correlates of second-line type 2 diabetes medication selection in the USA.

Ackermann, Ronald T; Wallia, Amisha; O'Brien, Matthew J; Kang, Raymond; Cooper, Andrew; Moran, Margaret R; Liss, David T

Ackermann, Ronald T; Wallia, Amisha; O'Brien, Matthew J; Kang, Raymond; Cooper, Andrew; Moran, Margaret R; Liss, David T.

Afiliación

Ackermann RT; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Wallia A; Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
O'Brien MJ; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Kang R; Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Cooper A; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Moran MR; Institute for Public Health and Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Liss DT; Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

BMJ Open Diabetes Res Care ; 5(1): e000421, 2017.

Article en En | MEDLINE | ID: mdl-29225892

Palabras clave

case comparison study design; diabetes mellitus; medication utilization; pharmacoepidemiology; type 2

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: BMJ Open Diabetes Res Care Año: 2017 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google